Table 1 The main clinicopathologic parameters of eligible women (n = 540)
From: Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer
| Â | n (%) |
|---|---|
Age, average, range a | 56 (30–76) |
Epithelial ovarian cancer b | Â |
EOC type I | 70/180 (39%) |
EOC type II | 110/180 (61%) |
Histological subtype | Â |
 Serous carcinoma   Low-grade   High-grade | 104/180 (59%) 16/180 (9%) 88/180 (50%) |
 Endometrioid carcinoma   Low-grade   High-grade | 28/180 (15%) 15/180 (8%) 13/180 (7%) |
 Clear cell carcinoma | 23/180 (13%) |
 Mucinous carcinoma  Undifferentiated carcinoma  Malignant mixed mesodermal tumor | 14/180 (8%) 7/180 (4%) 2/180 (1%) |
FIGO stage | Â |
 I | 47/180 (26%) |
 II | 17/180 (9%) |
 III | 97/180 (54%) |
 IV | 19/180 (11%) |
Tumor grade | Â |
 High | 54/180 (30%) |
 Moderate  Poor  Undifferentiated | 35/180 (19%) 84/180 (47%) 7/180 (4%) |
Benign ovarian cyst c | Â |
 Endometriosis | 104/180 (58%) |
 Serous cystadenoma | 24/180 (13%) |
 Mucinous cystadenoma  Simple cystadenoma | 29/180 (16%) 10/180 (6%) |
 Mature teratoma | 13/180 (7%) |